Katherine Stueland
CIK 1689575 · CHIEF EXECUTIVE OFFICER · last filed 2026-09-18
Katherine Stueland is a CHIEF EXECUTIVE OFFICER who has filed 122 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for WGS, was dated Sep 18, 2026. Across all open-market trades the lifetime net is −$46.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WGSWW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN FRANCISCO, CA 94107
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGS | CHIEF EXECUTIVE OFFICER | 124,181 | $61.26 | $7.61M | -$1.34M | 2 | 2026-09-18 |
| GeneDx Holdings Corp. (WGSWW) Delisted | CHIEF EXECUTIVE OFFICER | 112,733 | $0.00 | $23 | -$38.03M | 51 | 2026-06-18 |
| GeneDx Holdings Corp. (SMFRW) Delisted | Chief Executive Officer | 185,185 | $0.02 | $4.4K | $100.0K | 4 | 2022-12-14 |
| Invitae Corp (NVTA) Delisted | Chief Commercial Officer | 223,065 | $0.09 | $19.9K | -$7.16M | 44 | 2021-06-16 |
Recent Filings
122 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-18 | WGS | Mixed | +8,249 | -$1.03M | EDGAR |
| 2026-09-11 | WGS | Mixed | +2,855 | -$310.9K | EDGAR |
| 2026-09-01 | WGS | Notice (144) | −14,243 | -$1.21M | EDGAR |
| 2026-06-18 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +8,249 | -$638.1K | EDGAR |
| 2026-06-11 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +2,907 | -$195.7K | EDGAR |
| 2026-05-01 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +1,702 | -$141.6K | EDGAR |
| 2026-04-29 | WGS | Notice (144) | −16,415 | -$1.04M | EDGAR |
| 2026-03-30 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +33,067 | -$2.96M | EDGAR |
| 2026-03-17 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +13,492 | -$1.32M | EDGAR |
| 2026-03-11 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +2,868 | -$319.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.